These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 19317446)

  • 1. Discovery of novel 1-azoniabicyclo[2.2.2]octane muscarinic acetylcholine receptor antagonists.
    Lainé DI; McCleland B; Thomas S; Neipp C; Underwood B; Dufour J; Widdowson KL; Palovich MR; Blaney FE; Foley JJ; Webb EF; Luttmann MA; Burman M; Belmonte K; Salmon M
    J Med Chem; 2009 Apr; 52(8):2493-505. PubMed ID: 19317446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 2).
    Peretto I; Fossati C; Giardina GA; Giardini A; Guala M; La Porta E; Petrillo P; Radaelli S; Radice L; Raveglia LF; Santoro E; Scudellaro R; Scarpitta F; Cerri A; Menegon S; Dondio GM; Rizzi A; Armani E; Amari G; Civelli M; Villetti G; Patacchini R; Bergamaschi M; Bassani F; Delcanale M; Imbimbo BP
    J Med Chem; 2007 Apr; 50(7):1693-7. PubMed ID: 17352463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1).
    Peretto I; Forlani R; Fossati C; Giardina GA; Giardini A; Guala M; La Porta E; Petrillo P; Radaelli S; Radice L; Raveglia LF; Santoro E; Scudellaro R; Scarpitta F; Bigogno C; Misiano P; Dondio GM; Rizzi A; Armani E; Amari G; Civelli M; Villetti G; Patacchini R; Bergamaschi M; Delcanale M; Salcedo C; Fernández AG; Imbimbo BP
    J Med Chem; 2007 Apr; 50(7):1571-83. PubMed ID: 17352462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinol esters as potent and long-acting muscarinic antagonists with potential for minimal systemic exposure after inhaled administration: identification of (3R)-3-{[hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide (aclidinium bromide).
    Prat M; Fernández D; Buil MA; Crespo MI; Casals G; Ferrer M; Tort L; Castro J; Monleón JM; Gavaldà A; Miralpeix M; Ramos I; Doménech T; Vilella D; Antón F; Huerta JM; Espinosa S; López M; Sentellas S; González M; Albertí J; Segarra V; Cárdenas A; Beleta J; Ryder H
    J Med Chem; 2009 Aug; 52(16):5076-92. PubMed ID: 19653626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bronchodilator activity of (3R)-3-[[[(3-fluorophenyl)[(3,4,5-trifluorophenyl)methyl]amino] carbonyl]oxy]-1-[2-oxo-2-(2-thienyl)ethyl]-1-azoniabicyclo[2.2.2]octane bromide (CHF5407), a potent, long-acting, and selective muscarinic M3 receptor antagonist.
    Villetti G; Pastore F; Bergamaschi M; Bassani F; Bolzoni PT; Battipaglia L; Amari G; Rizzi A; Delcanale M; Volta R; Cenacchi V; Cacciani F; Zaniboni M; Berti F; Rossoni G; Harrison S; Petrillo P; Santoro E; Scudellaro R; Mannini F; Geppetti PA; Razzetti R; Patacchini R; Civelli M
    J Pharmacol Exp Ther; 2010 Dec; 335(3):622-35. PubMed ID: 20805306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhalation by design: novel tertiary amine muscarinic M₃ receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.
    Glossop PA; Watson CA; Price DA; Bunnage ME; Middleton DS; Wood A; James K; Roberts D; Strang RS; Yeadon M; Perros-Huguet C; Clarke NP; Trevethick MA; Machin I; Stuart EF; Evans SM; Harrison AC; Fairman DA; Agoram B; Burrows JL; Feeder N; Fulton CK; Dillon BR; Entwistle DA; Spence FJ
    J Med Chem; 2011 Oct; 54(19):6888-904. PubMed ID: 21870878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.
    Lainé DI; Wan Z; Yan H; Zhu C; Xie H; Fu W; Busch-Petersen J; Neipp C; Davis R; Widdowson KL; Blaney FE; Foley J; Bacon AM; Webb EF; Luttmann MA; Burman M; Sarau HM; Salmon M; Palovich MR; Belmonte K
    J Med Chem; 2009 Aug; 52(16):5241-52. PubMed ID: 19630384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antimuscarinic properties of quinuclidin-3-yl 1,2,3,4-tetrahydroisoquinoline-2-carboxylate derivatives as novel muscarinic receptor antagonists.
    Naito R; Yonetoku Y; Okamoto Y; Toyoshima A; Ikeda K; Takeuchi M
    J Med Chem; 2005 Oct; 48(21):6597-606. PubMed ID: 16220976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of biphenyl piperazines as novel and long acting muscarinic acetylcholine receptor antagonists.
    Jin J; Budzik B; Wang Y; Shi D; Wang F; Xie H; Wan Z; Zhu C; Foley JJ; Webb EF; Berlanga M; Burman M; Sarau HM; Morrow DM; Moore ML; Rivero RA; Palovich M; Salmon M; Belmonte KE; Lainé DI
    J Med Chem; 2008 Oct; 51(19):5915-8. PubMed ID: 18798607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of novel sulfonamide-containing bradykinin hB2 receptor antagonists. 2. Synthesis and structure-activity relationships of alpha,alpha-cycloalkylglycine sulfonamides.
    Fattori D; Rossi C; Fincham CI; Caciagli V; Catrambone F; D'Andrea P; Felicetti P; Gensini M; Marastoni E; Nannicini R; Paris M; Terracciano R; Bressan A; Giuliani S; Maggi CA; Meini S; Valenti C; Quartara L
    J Med Chem; 2007 Feb; 50(3):550-65. PubMed ID: 17266207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.
    Sagara Y; Sagara T; Uchiyama M; Otsuki S; Kimura T; Fujikawa T; Noguchi K; Ohtake N
    J Med Chem; 2006 Sep; 49(19):5653-63. PubMed ID: 16970392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1,4-dioxane, a suitable scaffold for the development of novel M₃ muscarinic receptor antagonists.
    Del Bello F; Barocelli E; Bertoni S; Bonifazi A; Camalli M; Campi G; Giannella M; Matucci R; Nesi M; Pigini M; Quaglia W; Piergentili A
    J Med Chem; 2012 Feb; 55(4):1783-7. PubMed ID: 22243489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological characterization of GSK573719 (umeclidinium): a novel, long-acting, inhaled antagonist of the muscarinic cholinergic receptors for treatment of pulmonary diseases.
    Salmon M; Luttmann MA; Foley JJ; Buckley PT; Schmidt DB; Burman M; Webb EF; DeHaas CJ; Kotzer CJ; Barrett VJ; Slack RJ; Sarau HM; Palovich MR; Lainé DI; Hay DW; Rumsey WL
    J Pharmacol Exp Ther; 2013 May; 345(2):260-70. PubMed ID: 23435542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alkyne-quinuclidine derivatives as potent and selective muscarinic antagonists for the treatment of COPD.
    Starck JP; Provins L; Christophe B; Gillard M; Jadot S; Lo Brutto P; Quéré L; Talaga P; Guyaux M
    Bioorg Med Chem Lett; 2008 Apr; 18(8):2675-8. PubMed ID: 18359633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel quinuclidinyl heteroarylcarbamate derivatives as muscarinic receptor antagonists.
    Nagashima S; Matsushima Y; Hamaguchi H; Nagata H; Kontani T; Moritomo A; Koshika T; Takeuchi M
    Bioorg Med Chem; 2014 Jul; 22(13):3478-87. PubMed ID: 24837158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3-(2-Benzofuranyl)quinuclidin-2-ene derivatives: novel muscarinic antagonists.
    Nordvall G; Sundquist S; Johansson G; Glas G; Nilvebrant L; Hacksell U
    J Med Chem; 1996 Aug; 39(17):3269-77. PubMed ID: 8765510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Influence of receptor kinetics on the onset and duration of action and the therapeutic index of NVA237 and tiotropium.
    Sykes DA; Dowling MR; Leighton-Davies J; Kent TC; Fawcett L; Renard E; Trifilieff A; Charlton SJ
    J Pharmacol Exp Ther; 2012 Nov; 343(2):520-8. PubMed ID: 22854200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent anti-muscarinic activity in a novel series of quinuclidine derivatives.
    Starck JP; Talaga P; Quéré L; Collart P; Christophe B; Lo Brutto P; Jadot S; Chimmanamada D; Zanda M; Wagner A; Mioskowski C; Massingham R; Guyaux M
    Bioorg Med Chem Lett; 2006 Jan; 16(2):373-7. PubMed ID: 16275087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ratiometric Ca+2 measurement in human recombinant muscarinic receptor subtypes using the Flexstation scanning fluorometer.
    Gupta S; Singh RK; Nanda K; Chatterjee M; Tiwari A; Sundaram S; Gupta D; Chugh A; Dastidar S; Ray A
    J Recept Signal Transduct Res; 2009; 29(2):100-6. PubMed ID: 19288301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of a new class of macrocyclic antagonists to the human motilin receptor.
    Marsault E; Hoveyda HR; Peterson ML; Saint-Louis C; Landry A; Vézina M; Ouellet L; Wang Z; Ramaseshan M; Beaubien S; Benakli K; Beauchemin S; Déziel R; Peeters T; Fraser GL
    J Med Chem; 2006 Nov; 49(24):7190-7. PubMed ID: 17125271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.